Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Tongjitang Chinese Medicines Co. is still considering the...
Sanofi-Aventis will acquire BMP Sunstone for $520...
Kangmei Pharma will raise up to $529 million through a...
In 2010, life science VC investing in China climbed an...
Fosun Pharma plans a $913 million IPO on the Hong Kong...
At the recent ChinaBio® Partnering Forum, three...
China earmarked 2 trillion RMB ($309 billion) for science...
Newsummit Pharma and the Cleveland Bio Fund established a...
On October 10-11, the ChinaBio® Leadership...
China National Biotechnology Group (CNBG) will raise as...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
